Medikabazaar Revenue and Competitors

Mumbai, India

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Medikabazaar's estimated annual revenue is currently $100.1M per year.(i)
  • Medikabazaar's estimated revenue per employee is $168,750

Employee Data

  • Medikabazaar has 593 Employees.(i)
  • Medikabazaar grew their employee count by 35% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$80.3M47627%N/AN/A
#2
$35.2M23730%N/AN/A
#3
$68.2M40422%N/AN/A
#4
$29.6M19916%N/AN/A
#5
$89.8M52417%$13.2MN/A
#6
$102.8M609-2%N/AN/A
#7
$100.1M59335%N/AN/A
#8
$39.5M26625%N/AN/A
#9
$148.7M7878%N/AN/A
#10
$10.8M805%N/AN/A
Add Company

MedikaBazaar, is India's largest online aggregator of medical supplies offering a host of benefits to hospitals & medical establishments. Currently MedikaBazaar has over 6000+ hospitals & medical institutions registered & more than 4000+ customers buying regularly from the platform, our customers include leading hospitals such as Apollo Hospitals (Nationwide), Fortis, Manipal, Global Hospitals, Sparsh Nephrocare, Asian Cancer Institute, Saifee Hospital etc to name a few. Our focus remains largely on tier II & III cities reaching out to meet the last mile requirement for medical supplies. We have already enrolled with many Domestic and International brands such as Philips, Nipro, Fresenius, Allmed, BPL, Appasamy, Megadyne, Buffalo filter (from Filtration group US), Belmont Instruments, Gamidatech, Tortle, HMD, BD, Defibtech, PMT healthcare, Welmed, 3M etc. We are also in advance talks with few leading brands to be enrolled shortly. Moreover, we also attract many new and innovative medical innovations both domestic and international, such as Lattice Innovations, Forus health, Galtron, Gemi, Jaywant Surgical, Kaavya Industries, B V Cotton etc. We cater to approximately 2 lakhs bed+ across India. Over and above we get 100+ new enquiries on a daily basis from various hospitals, nursing homes, doctors etc. We focus on all medical specialities which include Oncology, Nephrology, Urology, Cardiology, Pathology & Diagnostics, Pediatrics, Orthopedics, Ophthalmology, General surgical Items & Supplies, Surgical Instruments, Dentistry, Trauma care, ICU / NICU equipment, Gynecology & Maternity, Radiology etc (please visit https://medikabazaar.com). Please go through our concept video at the link (https://www.youtube.com/watchv=Ynv0CuMpHGs)

keywords:N/A

N/A

Total Funding

593

Number of Employees

$100.1M

Revenue (est)

35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medikabazaar News

2022-04-13 - MedikaBazaar raises $65 Mn in Series D at $700 Mn valuation

Founded by Vivek Tiwari and Ketan Malkan, seven-year-old Medikabazaar enables hospitals and medical establishments to discover supplies, compare...

2022-04-13 - ETtech Deals Digest: Rapido, Medikabazaar, Itilite raise funds

Bike and auto taxi aggregator Rapido, business-to-business (B2B) medical supply platform Medikabazaar and travel and expense (T&E)...

2022-04-13 - Medikabazaar raises $65 M in new round led by Lighthouse

Lighthouse India Fund III has led a new round of $65 million in Mumbai-based startup Medikabazaar, a B2B medical supply chain platform.

2021-09-24 - Healthtech platform Medikabazaar raises $75 million from Creagis, CDC Group

Healthtech platform, Medikabazaar, on September 24 announced that it has raised $75 million as a part of its Series C investment led by Creagis, along with CDC Group, UK’s development finance institution. The round also saw participation from existing investors including Belgium-based Ackermans ...

2021-09-24 - India based Healthcare Medikabazaar raises USD 75 million in Series C round

Medikabazaar, an Indian Healthtech startup, raised USD 75 million in a Series C funding round led by Creagis, along with CDC Group, UK’s development finance institution, on 24 September 2021. Investors: Creagis and CDC group, wholly-owned development finance institution of UK Government, co-led ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$52M594-25%N/A
#2
$100.6M596-8%N/A
#3
$156.5M59671%N/A
#4
$100.7M59720%N/A
#5
$78.9M60122%N/A